Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects

Identifieur interne : 000994 ( Istex/Corpus ); précédent : 000993; suivant : 000995

Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects

Auteurs : A. Bikfalvi ; C. Sauzeau ; H. Moukadiri ; J. Maclouf ; N. Busso ; M. Bryckaert ; J. Plouet ; G. Tobelem

Source :

RBID : ISTEX:D65D97CC8479F9BF9489CDDB588AF8E067E434AA

English descriptors

Abstract

Vasculotropin/vascular endothelial cell growth factor (VAS/VEGF) is a newly purified growth factor with a unique specificity for vascular endothelial cells. We have investigated the interactions of VAS/VEGF with human umbilical vein endothelial cells (HUVE cells). 125I‐VAS/VEGF was bound to HUVE cells in a saturable manner with a half‐maximum binding at 2.8 ng/ml. Scatchard analysis did show two classes of high‐affinity binding sites. The first class displayed a dissociation constant of 9 pM with 500 sites/cell. The dissociation constant and the number of binding sites of the second binding class were variable for different HUVE cell cultures (KD = 179 ± 101 pM, 5,850 ± 2,950 sites/cell). Half‐maximal inhibition of 125I‐VAS/VEGF occurred with a threefold excess of unlabeled ligand. Basic fibroblast growth factor (bFGF) and heparin did not compete with 125I‐VAS/VEGF binding. In contrast, suramin and protamin sulfate completely displaced 125I‐VAS/VEGF binding from HUVE cells. VAS/VEGF was shown to be internalized in HUVE cells. Maximum internalization (55% of total cell‐associated radioactivity) was observed after 30 min. 125I‐VAS/VEGF was completely degraded 2–3 hr after binding. At 3 hr, the trichloroacetic acid (TCA)‐soluble radioactivity accumulated in the medium was 60% of the total radioactivity released by HUVE cells. No degradation fragment of 125I‐VAS/VEGF was observed. Chloroquine completely inhibited degradation. VAS/VEGF was able to induce angiogenesis in vitro in HUVE cells. However, it did not significantly modulate urokinase‐type plasminogen activator (u‐PA), tissue‐type plasminogen activator (t‐PA), plasminogen activator inhibitor (PAI‐1), and tissue factor (TF). Prostacyclin production was only stimulated at very high VAS/VEGF concentrations. Taken together, these results indicate that VAS/VEGF might be a potent inducer of neovascularization resulting from a direct interaction with endothelial cells. The angiogenic activity seems to be independent of the plasminogen activator or inhibitor system.

Url:
DOI: 10.1002/jcp.1041490108

Links to Exploration step

ISTEX:D65D97CC8479F9BF9489CDDB588AF8E067E434AA

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects</title>
<author>
<name sortKey="Bikfalvi, A" sort="Bikfalvi, A" uniqKey="Bikfalvi A" first="A." last="Bikfalvi">A. Bikfalvi</name>
<affiliation>
<mods:affiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Current Address: Department of Cell Biology, New York University Medical Center, 550 First Avenue, New York, NY 10076</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Correspondence address: Department of Cell Biology, New York University Medical Center, 550 First Avenue, New York, NY 10076</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sauzeau, C" sort="Sauzeau, C" uniqKey="Sauzeau C" first="C." last="Sauzeau">C. Sauzeau</name>
<affiliation>
<mods:affiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Moukadiri, H" sort="Moukadiri, H" uniqKey="Moukadiri H" first="H." last="Moukadiri">H. Moukadiri</name>
<affiliation>
<mods:affiliation>INSERM U 86, Centre des Cordeliers, 75006 Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Current Address: ATIP, Centre de Recherches en Biochimie et Genetique Cellulaire, 114 route de Narbonne, 3100 Toulouse, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Maclouf, J" sort="Maclouf, J" uniqKey="Maclouf J" first="J." last="Maclouf">J. Maclouf</name>
<affiliation>
<mods:affiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Busso, N" sort="Busso, N" uniqKey="Busso N" first="N." last="Busso">N. Busso</name>
<affiliation>
<mods:affiliation>Laboratoires Glaxo, 91940 Les Ulis, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bryckaert, M" sort="Bryckaert, M" uniqKey="Bryckaert M" first="M." last="Bryckaert">M. Bryckaert</name>
<affiliation>
<mods:affiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Plouet, J" sort="Plouet, J" uniqKey="Plouet J" first="J." last="Plouet">J. Plouet</name>
<affiliation>
<mods:affiliation>INSERM U 86, Centre des Cordeliers, 75006 Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Current Address: ATIP, Centre de Recherches en Biochimie et Genetique Cellulaire, 114 route de Narbonne, 3100 Toulouse, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tobelem, G" sort="Tobelem, G" uniqKey="Tobelem G" first="G." last="Tobelem">G. Tobelem</name>
<affiliation>
<mods:affiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D65D97CC8479F9BF9489CDDB588AF8E067E434AA</idno>
<date when="1991" year="1991">1991</date>
<idno type="doi">10.1002/jcp.1041490108</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-CDHTF6T2-B/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000994</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000994</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects</title>
<author>
<name sortKey="Bikfalvi, A" sort="Bikfalvi, A" uniqKey="Bikfalvi A" first="A." last="Bikfalvi">A. Bikfalvi</name>
<affiliation>
<mods:affiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Current Address: Department of Cell Biology, New York University Medical Center, 550 First Avenue, New York, NY 10076</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Correspondence address: Department of Cell Biology, New York University Medical Center, 550 First Avenue, New York, NY 10076</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sauzeau, C" sort="Sauzeau, C" uniqKey="Sauzeau C" first="C." last="Sauzeau">C. Sauzeau</name>
<affiliation>
<mods:affiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Moukadiri, H" sort="Moukadiri, H" uniqKey="Moukadiri H" first="H." last="Moukadiri">H. Moukadiri</name>
<affiliation>
<mods:affiliation>INSERM U 86, Centre des Cordeliers, 75006 Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Current Address: ATIP, Centre de Recherches en Biochimie et Genetique Cellulaire, 114 route de Narbonne, 3100 Toulouse, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Maclouf, J" sort="Maclouf, J" uniqKey="Maclouf J" first="J." last="Maclouf">J. Maclouf</name>
<affiliation>
<mods:affiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Busso, N" sort="Busso, N" uniqKey="Busso N" first="N." last="Busso">N. Busso</name>
<affiliation>
<mods:affiliation>Laboratoires Glaxo, 91940 Les Ulis, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bryckaert, M" sort="Bryckaert, M" uniqKey="Bryckaert M" first="M." last="Bryckaert">M. Bryckaert</name>
<affiliation>
<mods:affiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Plouet, J" sort="Plouet, J" uniqKey="Plouet J" first="J." last="Plouet">J. Plouet</name>
<affiliation>
<mods:affiliation>INSERM U 86, Centre des Cordeliers, 75006 Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Current Address: ATIP, Centre de Recherches en Biochimie et Genetique Cellulaire, 114 route de Narbonne, 3100 Toulouse, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tobelem, G" sort="Tobelem, G" uniqKey="Tobelem G" first="G." last="Tobelem">G. Tobelem</name>
<affiliation>
<mods:affiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Cellular Physiology</title>
<title level="j" type="alt">JOURNAL OF CELLULAR PHYSIOLOGY</title>
<idno type="ISSN">0021-9541</idno>
<idno type="eISSN">1097-4652</idno>
<imprint>
<biblScope unit="vol">149</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="50">50</biblScope>
<biblScope unit="page" to="59">59</biblScope>
<biblScope unit="page-count">10</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1991-10">1991-10</date>
</imprint>
<idno type="ISSN">0021-9541</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0021-9541</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acad</term>
<term>Acidic</term>
<term>Acidic wash</term>
<term>Activator</term>
<term>Amino acids</term>
<term>Angiogenesis</term>
<term>Angiogenic</term>
<term>Assay</term>
<term>Basic fibroblast growth factor</term>
<term>Bfgf</term>
<term>Bikfalvi</term>
<term>Binding sites</term>
<term>Biol</term>
<term>Bovine</term>
<term>Bovine capillary</term>
<term>Cell biol</term>
<term>Cell growth factor</term>
<term>Cell surface binding</term>
<term>Chloroquine</term>
<term>Collagen type</term>
<term>Connolly</term>
<term>Degradation</term>
<term>Degraded</term>
<term>Endothelial</term>
<term>Endothelial cell mitogen</term>
<term>Endothelial cells</term>
<term>Fibroblast</term>
<term>Gospodarowicz</term>
<term>Growth factor</term>
<term>Growth factors</term>
<term>Heparin</term>
<term>Human umbilical vein</term>
<term>Huve</term>
<term>Huve cells</term>
<term>Incubation medium</term>
<term>Inhibitor</term>
<term>Internalization</term>
<term>Ligand</term>
<term>Montesano</term>
<term>Moukadiri</term>
<term>Natl</term>
<term>Ngiml</term>
<term>Orci</term>
<term>Physiol</term>
<term>Plasminogen</term>
<term>Plasminogen activator</term>
<term>Plasminogen activators</term>
<term>Plouet</term>
<term>Proc</term>
<term>Procoagulant</term>
<term>Procoagulant activity</term>
<term>Prostacyclin</term>
<term>Prostacyclin production</term>
<term>Protamin</term>
<term>Radioactivity</term>
<term>Receptor</term>
<term>Tissue factor</term>
<term>Total radioactivity</term>
<term>Umbilical</term>
<term>Unlabeled</term>
<term>Unlabeled ligand</term>
<term>Unstimulated control</term>
<term>Vascular permeability factor</term>
<term>Vasculotropin</term>
<term>Vasculotropin effect</term>
<term>Vasi vegf</term>
<term>Vasivegf</term>
<term>Vegf</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Vasculotropin/vascular endothelial cell growth factor (VAS/VEGF) is a newly purified growth factor with a unique specificity for vascular endothelial cells. We have investigated the interactions of VAS/VEGF with human umbilical vein endothelial cells (HUVE cells). 125I‐VAS/VEGF was bound to HUVE cells in a saturable manner with a half‐maximum binding at 2.8 ng/ml. Scatchard analysis did show two classes of high‐affinity binding sites. The first class displayed a dissociation constant of 9 pM with 500 sites/cell. The dissociation constant and the number of binding sites of the second binding class were variable for different HUVE cell cultures (KD = 179 ± 101 pM, 5,850 ± 2,950 sites/cell). Half‐maximal inhibition of 125I‐VAS/VEGF occurred with a threefold excess of unlabeled ligand. Basic fibroblast growth factor (bFGF) and heparin did not compete with 125I‐VAS/VEGF binding. In contrast, suramin and protamin sulfate completely displaced 125I‐VAS/VEGF binding from HUVE cells. VAS/VEGF was shown to be internalized in HUVE cells. Maximum internalization (55% of total cell‐associated radioactivity) was observed after 30 min. 125I‐VAS/VEGF was completely degraded 2–3 hr after binding. At 3 hr, the trichloroacetic acid (TCA)‐soluble radioactivity accumulated in the medium was 60% of the total radioactivity released by HUVE cells. No degradation fragment of 125I‐VAS/VEGF was observed. Chloroquine completely inhibited degradation. VAS/VEGF was able to induce angiogenesis in vitro in HUVE cells. However, it did not significantly modulate urokinase‐type plasminogen activator (u‐PA), tissue‐type plasminogen activator (t‐PA), plasminogen activator inhibitor (PAI‐1), and tissue factor (TF). Prostacyclin production was only stimulated at very high VAS/VEGF concentrations. Taken together, these results indicate that VAS/VEGF might be a potent inducer of neovascularization resulting from a direct interaction with endothelial cells. The angiogenic activity seems to be independent of the plasminogen activator or inhibitor system.</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<keywords>
<teeft>
<json:string>vasivegf</json:string>
<json:string>huve</json:string>
<json:string>huve cells</json:string>
<json:string>plasminogen</json:string>
<json:string>activator</json:string>
<json:string>angiogenesis</json:string>
<json:string>prostacyclin</json:string>
<json:string>bfgf</json:string>
<json:string>ngiml</json:string>
<json:string>angiogenic</json:string>
<json:string>montesano</json:string>
<json:string>fibroblast</json:string>
<json:string>receptor</json:string>
<json:string>internalization</json:string>
<json:string>prostacyclin production</json:string>
<json:string>growth factor</json:string>
<json:string>plouet</json:string>
<json:string>basic fibroblast growth factor</json:string>
<json:string>biol</json:string>
<json:string>orci</json:string>
<json:string>endothelial cells</json:string>
<json:string>binding sites</json:string>
<json:string>chloroquine</json:string>
<json:string>endothelial</json:string>
<json:string>bikfalvi</json:string>
<json:string>natl</json:string>
<json:string>unlabeled</json:string>
<json:string>acad</json:string>
<json:string>vegf</json:string>
<json:string>heparin</json:string>
<json:string>umbilical</json:string>
<json:string>moukadiri</json:string>
<json:string>total radioactivity</json:string>
<json:string>vasculotropin</json:string>
<json:string>proc</json:string>
<json:string>physiol</json:string>
<json:string>plasminogen activator</json:string>
<json:string>procoagulant</json:string>
<json:string>protamin</json:string>
<json:string>gospodarowicz</json:string>
<json:string>growth factors</json:string>
<json:string>human umbilical vein</json:string>
<json:string>cell growth factor</json:string>
<json:string>acidic</json:string>
<json:string>procoagulant activity</json:string>
<json:string>unlabeled ligand</json:string>
<json:string>radioactivity</json:string>
<json:string>assay</json:string>
<json:string>ligand</json:string>
<json:string>plasminogen activators</json:string>
<json:string>acidic wash</json:string>
<json:string>cell biol</json:string>
<json:string>vasculotropin effect</json:string>
<json:string>bovine capillary</json:string>
<json:string>collagen type</json:string>
<json:string>amino acids</json:string>
<json:string>endothelial cell mitogen</json:string>
<json:string>tissue factor</json:string>
<json:string>vasi vegf</json:string>
<json:string>degradation</json:string>
<json:string>connolly</json:string>
<json:string>degraded</json:string>
<json:string>bovine</json:string>
<json:string>inhibitor</json:string>
<json:string>incubation medium</json:string>
<json:string>unstimulated control</json:string>
<json:string>cell surface binding</json:string>
<json:string>vascular permeability factor</json:string>
</teeft>
</keywords>
<author>
<json:item>
<name>A. Bikfalvi</name>
<affiliations>
<json:string>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</json:string>
<json:string>Current Address: Department of Cell Biology, New York University Medical Center, 550 First Avenue, New York, NY 10076</json:string>
<json:string>Correspondence address: Department of Cell Biology, New York University Medical Center, 550 First Avenue, New York, NY 10076</json:string>
</affiliations>
</json:item>
<json:item>
<name>C. Sauzeau</name>
<affiliations>
<json:string>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>H. Moukadiri</name>
<affiliations>
<json:string>INSERM U 86, Centre des Cordeliers, 75006 Paris, France</json:string>
<json:string>Current Address: ATIP, Centre de Recherches en Biochimie et Genetique Cellulaire, 114 route de Narbonne, 3100 Toulouse, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>J. Maclouf</name>
<affiliations>
<json:string>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>N. Busso</name>
<affiliations>
<json:string>Laboratoires Glaxo, 91940 Les Ulis, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>M. Bryckaert</name>
<affiliations>
<json:string>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>J. Plouet</name>
<affiliations>
<json:string>INSERM U 86, Centre des Cordeliers, 75006 Paris, France</json:string>
<json:string>Current Address: ATIP, Centre de Recherches en Biochimie et Genetique Cellulaire, 114 route de Narbonne, 3100 Toulouse, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>G. Tobelem</name>
<affiliations>
<json:string>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</json:string>
</affiliations>
</json:item>
</author>
<articleId>
<json:string>JCP1041490108</json:string>
</articleId>
<arkIstex>ark:/67375/WNG-CDHTF6T2-B</arkIstex>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>article</json:string>
</originalGenre>
<abstract>Vasculotropin/vascular endothelial cell growth factor (VAS/VEGF) is a newly purified growth factor with a unique specificity for vascular endothelial cells. We have investigated the interactions of VAS/VEGF with human umbilical vein endothelial cells (HUVE cells). 125I‐VAS/VEGF was bound to HUVE cells in a saturable manner with a half‐maximum binding at 2.8 ng/ml. Scatchard analysis did show two classes of high‐affinity binding sites. The first class displayed a dissociation constant of 9 pM with 500 sites/cell. The dissociation constant and the number of binding sites of the second binding class were variable for different HUVE cell cultures (KD = 179 ± 101 pM, 5,850 ± 2,950 sites/cell). Half‐maximal inhibition of 125I‐VAS/VEGF occurred with a threefold excess of unlabeled ligand. Basic fibroblast growth factor (bFGF) and heparin did not compete with 125I‐VAS/VEGF binding. In contrast, suramin and protamin sulfate completely displaced 125I‐VAS/VEGF binding from HUVE cells. VAS/VEGF was shown to be internalized in HUVE cells. Maximum internalization (55% of total cell‐associated radioactivity) was observed after 30 min. 125I‐VAS/VEGF was completely degraded 2–3 hr after binding. At 3 hr, the trichloroacetic acid (TCA)‐soluble radioactivity accumulated in the medium was 60% of the total radioactivity released by HUVE cells. No degradation fragment of 125I‐VAS/VEGF was observed. Chloroquine completely inhibited degradation. VAS/VEGF was able to induce angiogenesis in vitro in HUVE cells. However, it did not significantly modulate urokinase‐type plasminogen activator (u‐PA), tissue‐type plasminogen activator (t‐PA), plasminogen activator inhibitor (PAI‐1), and tissue factor (TF). Prostacyclin production was only stimulated at very high VAS/VEGF concentrations. Taken together, these results indicate that VAS/VEGF might be a potent inducer of neovascularization resulting from a direct interaction with endothelial cells. The angiogenic activity seems to be independent of the plasminogen activator or inhibitor system.</abstract>
<qualityIndicators>
<score>10</score>
<pdfWordCount>6585</pdfWordCount>
<pdfCharCount>41524</pdfCharCount>
<pdfVersion>1.3</pdfVersion>
<pdfPageCount>10</pdfPageCount>
<pdfPageSize>594 x 792 pts</pdfPageSize>
<pdfWordsPerPage>659</pdfWordsPerPage>
<pdfText>true</pdfText>
<refBibsNative>true</refBibsNative>
<abstractWordCount>285</abstractWordCount>
<abstractCharCount>2046</abstractCharCount>
<keywordCount>0</keywordCount>
</qualityIndicators>
<title>Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects</title>
<pmid>
<json:string>1719003</json:string>
</pmid>
<genre>
<json:string>article</json:string>
</genre>
<host>
<title>Journal of Cellular Physiology</title>
<language>
<json:string>unknown</json:string>
</language>
<doi>
<json:string>10.1002/(ISSN)1097-4652</json:string>
</doi>
<issn>
<json:string>0021-9541</json:string>
</issn>
<eissn>
<json:string>1097-4652</json:string>
</eissn>
<publisherId>
<json:string>JCP</json:string>
</publisherId>
<volume>149</volume>
<issue>1</issue>
<pages>
<first>50</first>
<last>59</last>
<total>10</total>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
<subject>
<json:item>
<value>Article</value>
</json:item>
<json:item>
<value>Articles</value>
</json:item>
</subject>
</host>
<namedEntities>
<unitex>
<date>
<json:string>1991</json:string>
<json:string>1251</json:string>
</date>
<geogName></geogName>
<orgName>
<json:string>Mobay Inc.</json:string>
<json:string>Pharmacia</json:string>
<json:string>Research</json:string>
<json:string>LISS, INC</json:string>
<json:string>American Diagnostica</json:string>
<json:string>Department of Cell Biology, New York University Medical Center</json:string>
<json:string>Biochem</json:string>
<json:string>American Diagnostica, Greenwich, CT</json:string>
<json:string>Rad</json:string>
</orgName>
<orgName_funder></orgName_funder>
<orgName_provider></orgName_provider>
<persName>
<json:string>P.M. Henson</json:string>
<json:string>J. Plouet</json:string>
<json:string>J. Biol</json:string>
<json:string>J. Cell</json:string>
<json:string>J. Abraham</json:string>
<json:string>NY Acad</json:string>
<json:string>J. Exp</json:string>
<json:string>B. Murphy</json:string>
<json:string>J. Natl</json:string>
<json:string>J. Clin</json:string>
<json:string>D. Hicks</json:string>
</persName>
<placeName>
<json:string>Bedford</json:string>
<json:string>Uppsala</json:string>
<json:string>Paris</json:string>
<json:string>Greenwich</json:string>
<json:string>NY</json:string>
<json:string>Richmond</json:string>
<json:string>Mannheim</json:string>
<json:string>Kuwashima</json:string>
<json:string>Narbonne</json:string>
<json:string>VA</json:string>
<json:string>CT</json:string>
<json:string>Ferrara</json:string>
<json:string>Amsterdam</json:string>
<json:string>Toulouse</json:string>
<json:string>CA</json:string>
<json:string>MA</json:string>
<json:string>France</json:string>
<json:string>Sweden</json:string>
<json:string>Mountain View</json:string>
</placeName>
<ref_url></ref_url>
<ref_bibl>
<json:string>Plouet and Moukadiri, 1990a,b</json:string>
<json:string>Hasegawa et al., 1988</json:string>
<json:string>Pradelles et al., 1985</json:string>
<json:string>Bevilacqua et al., 1984, 1986</json:string>
<json:string>Moukadiri et al., 1990</json:string>
<json:string>Phillips et al. (1990)</json:string>
<json:string>Connolly et al., 1989a</json:string>
<json:string>Montesano and Orci, 1987</json:string>
<json:string>Weksler, 1990</json:string>
<json:string>Connolly et al. (198913)</json:string>
<json:string>Moenner et al., 1989</json:string>
<json:string>Plouet and Moukadiri, 1990b</json:string>
<json:string>Leung et al., 1989</json:string>
<json:string>Saksela et al., 1987</json:string>
<json:string>Kieffer et al., 1990</json:string>
<json:string>Neufeld and Gospodarowicz, 1987</json:string>
<json:string>McNeil et al., 1989</json:string>
<json:string>Pepper et al., 1990</json:string>
<json:string>Montesano and Orci, 1985, 1987</json:string>
<json:string>Bikfalvi et al., 1989</json:string>
<json:string>Moscatelli, 1987, 1988</json:string>
<json:string>Kuwashima et al., 1988</json:string>
<json:string>Zavoico et al., 1990</json:string>
<json:string>Madri et al., 1988</json:string>
<json:string>Moscatelli, 1988</json:string>
<json:string>Greenwood et al., 1963</json:string>
<json:string>Levy et al., 1990</json:string>
<json:string>Vaisman et al., 1990</json:string>
<json:string>Voelkel, 1989</json:string>
<json:string>Haigler et al. (1985)</json:string>
<json:string>Jaffe et al. (1973)</json:string>
<json:string>Connolly et al., 1989a,b</json:string>
<json:string>Montesano and Orci (1985)</json:string>
<json:string>Plouet et al., 1989</json:string>
<json:string>Ziche et al., 1982</json:string>
<json:string>Frater-Schroder et al., 1987</json:string>
<json:string>Gospodarowicz et al., 1989</json:string>
<json:string>Conn et al., 1990</json:string>
<json:string>Coffrey et al., 1987</json:string>
<json:string>Gadjusek and Carbon, 19891</json:string>
<json:string>Conn et al., 1989</json:string>
<json:string>Witte et al., 1989</json:string>
<json:string>Tischer et al., 1989</json:string>
<json:string>Brevario et al., 1990</json:string>
<json:string>Montesano et al., 1986</json:string>
<json:string>Heldin et al., 1981</json:string>
</ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark>
<json:string>ark:/67375/WNG-CDHTF6T2-B</json:string>
</ark>
<categories>
<wos>
<json:string>1 - science</json:string>
<json:string>2 - physiology</json:string>
<json:string>2 - cell biology</json:string>
</wos>
<scienceMetrix>
<json:string>1 - health sciences</json:string>
<json:string>2 - biomedical research</json:string>
<json:string>3 - biochemistry & molecular biology</json:string>
</scienceMetrix>
<scopus>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Cell Biology</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Clinical Biochemistry</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Physiology</json:string>
</scopus>
<inist>
<json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences medicales</json:string>
<json:string>4 - pharmacologie. traitements medicamenteux</json:string>
</inist>
</categories>
<publicationDate>1991</publicationDate>
<copyrightDate>1991</copyrightDate>
<doi>
<json:string>10.1002/jcp.1041490108</json:string>
</doi>
<id>D65D97CC8479F9BF9489CDDB588AF8E067E434AA</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-CDHTF6T2-B/fulltext.pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-CDHTF6T2-B/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-CDHTF6T2-B/fulltext.tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main">Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects</title>
<title level="a" type="short" xml:lang="en">VASCULOTROPIN EFFECT ON HUVE CELLS</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability>
<licence>Copyright © 1991 Wiley‐Liss, Inc.</licence>
</availability>
<date type="published" when="1991-10"></date>
</publicationStmt>
<notesStmt>
<note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note>
<note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc>
<biblStruct type="article">
<analytic>
<title level="a" type="main">Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects</title>
<title level="a" type="short" xml:lang="en">VASCULOTROPIN EFFECT ON HUVE CELLS</title>
<author xml:id="author-0000" role="corresp">
<persName>
<forename type="first">A.</forename>
<surname>Bikfalvi</surname>
</persName>
<affiliation>
<address>
<addrLine>INSERM U 150</addrLine>
<addrLine>Hopital Lariboisière, 75010 Paris, France</addrLine>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
<affiliation>
<orgName type="laboratory">Department of Cell Biology</orgName>
<orgName type="institution">New York University Medical Center</orgName>
<address>
<addrLine>550 First Avenue</addrLine>
<addrLine>New York, NY 10076</addrLine>
<country key="US" xml:lang="en">UNITED STATES</country>
</address>
</affiliation>
</author>
<author xml:id="author-0001">
<persName>
<forename type="first">C.</forename>
<surname>Sauzeau</surname>
</persName>
<affiliation>
<address>
<addrLine>INSERM U 150</addrLine>
<addrLine>Hopital Lariboisière, 75010 Paris, France</addrLine>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author xml:id="author-0002">
<persName>
<forename type="first">H.</forename>
<surname>Moukadiri</surname>
</persName>
<affiliation>
<address>
<addrLine>INSERM U 86</addrLine>
<addrLine>Centre des Cordeliers, 75006 Paris, France</addrLine>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
<affiliation>
<address>
<addrLine>ATIP</addrLine>
<addrLine>Centre de Recherches en Biochimie et Genetique Cellulaire, 114 route de Narbonne, 3100 Toulouse, France</addrLine>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author xml:id="author-0003">
<persName>
<forename type="first">J.</forename>
<surname>Maclouf</surname>
</persName>
<affiliation>
<address>
<addrLine>INSERM U 150</addrLine>
<addrLine>Hopital Lariboisière, 75010 Paris, France</addrLine>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author xml:id="author-0004">
<persName>
<forename type="first">N.</forename>
<surname>Busso</surname>
</persName>
<affiliation>
<orgName type="laboratory">Laboratoires Glaxo</orgName>
<address>
<addrLine>91940 Les Ulis</addrLine>
<addrLine>France</addrLine>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author xml:id="author-0005">
<persName>
<forename type="first">M.</forename>
<surname>Bryckaert</surname>
</persName>
<affiliation>
<address>
<addrLine>INSERM U 150</addrLine>
<addrLine>Hopital Lariboisière, 75010 Paris, France</addrLine>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author xml:id="author-0006">
<persName>
<forename type="first">J.</forename>
<surname>Plouet</surname>
</persName>
<affiliation>
<address>
<addrLine>INSERM U 86</addrLine>
<addrLine>Centre des Cordeliers, 75006 Paris, France</addrLine>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
<affiliation>
<address>
<addrLine>ATIP</addrLine>
<addrLine>Centre de Recherches en Biochimie et Genetique Cellulaire, 114 route de Narbonne, 3100 Toulouse, France</addrLine>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author xml:id="author-0007">
<persName>
<forename type="first">G.</forename>
<surname>Tobelem</surname>
</persName>
<affiliation>
<address>
<addrLine>INSERM U 150</addrLine>
<addrLine>Hopital Lariboisière, 75010 Paris, France</addrLine>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<idno type="istex">D65D97CC8479F9BF9489CDDB588AF8E067E434AA</idno>
<idno type="ark">ark:/67375/WNG-CDHTF6T2-B</idno>
<idno type="DOI">10.1002/jcp.1041490108</idno>
<idno type="unit">JCP1041490108</idno>
<idno type="toTypesetVersion">file:JCP.JCP1041490108.pdf</idno>
</analytic>
<monogr>
<title level="j" type="main">Journal of Cellular Physiology</title>
<title level="j" type="alt">JOURNAL OF CELLULAR PHYSIOLOGY</title>
<idno type="pISSN">0021-9541</idno>
<idno type="eISSN">1097-4652</idno>
<idno type="book-DOI">10.1002/(ISSN)1097-4652</idno>
<idno type="book-part-DOI">10.1002/jcp.v149:1</idno>
<idno type="product">JCP</idno>
<imprint>
<biblScope unit="vol">149</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="50">50</biblScope>
<biblScope unit="page" to="59">59</biblScope>
<biblScope unit="page-count">10</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1991-10"></date>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<encodingDesc>
<schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef>
<appInfo>
<application ident="pub2tei" version="1.0.10" when="2019-12-20">
<label>pub2TEI-ISTEX</label>
<desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref>
</desc>
</application>
</appInfo>
</encodingDesc>
<profileDesc>
<abstract xml:lang="en" style="main">
<head>Abstract</head>
<p>Vasculotropin/vascular endothelial cell growth factor (VAS/VEGF) is a newly purified growth factor with a unique specificity for vascular endothelial cells. We have investigated the interactions of VAS/VEGF with human umbilical vein endothelial cells (HUVE cells).
<hi rend="superscript">125</hi>
I‐VAS/VEGF was bound to HUVE cells in a saturable manner with a half‐maximum binding at 2.8 ng/ml. Scatchard analysis did show two classes of high‐affinity binding sites. The first class displayed a dissociation constant of 9 pM with 500 sites/cell. The dissociation constant and the number of binding sites of the second binding class were variable for different HUVE cell cultures (K
<hi rend="subscript">D</hi>
= 179 ± 101 pM, 5,850 ± 2,950 sites/cell). Half‐maximal inhibition of
<hi rend="superscript">125</hi>
I‐VAS/VEGF occurred with a threefold excess of unlabeled ligand. Basic fibroblast growth factor (bFGF) and heparin did not compete with
<hi rend="superscript">125</hi>
I‐VAS/VEGF binding. In contrast, suramin and protamin sulfate completely displaced
<hi rend="superscript">125</hi>
I‐VAS/VEGF binding from HUVE cells. VAS/VEGF was shown to be internalized in HUVE cells. Maximum internalization (55% of total cell‐associated radioactivity) was observed after 30 min.
<hi rend="superscript">125</hi>
I‐VAS/VEGF was completely degraded 2–3 hr after binding. At 3 hr, the trichloroacetic acid (TCA)‐soluble radioactivity accumulated in the medium was 60% of the total radioactivity released by HUVE cells. No degradation fragment of
<hi rend="superscript">125</hi>
I‐VAS/VEGF was observed. Chloroquine completely inhibited degradation. VAS/VEGF was able to induce angiogenesis in vitro in HUVE cells. However, it did not significantly modulate urokinase‐type plasminogen activator (u‐PA), tissue‐type plasminogen activator (t‐PA), plasminogen activator inhibitor (PAI‐1), and tissue factor (TF). Prostacyclin production was only stimulated at very high VAS/VEGF concentrations. Taken together, these results indicate that VAS/VEGF might be a potent inducer of neovascularization resulting from a direct interaction with endothelial cells. The angiogenic activity seems to be independent of the plasminogen activator or inhibitor system.</p>
</abstract>
<textClass>
<keywords rend="articleCategory">
<term>Article</term>
</keywords>
<keywords rend="tocHeading1">
<term>Articles</term>
</keywords>
</textClass>
<langUsage>
<language ident="en"></language>
</langUsage>
</profileDesc>
<revisionDesc>
<change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-CDHTF6T2-B/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1097-4652</doi>
<issn type="print">0021-9541</issn>
<issn type="electronic">1097-4652</issn>
<idGroup>
<id type="product" value="JCP"></id>
</idGroup>
<titleGroup>
<title type="main" xml:lang="en" sort="JOURNAL OF CELLULAR PHYSIOLOGY">Journal of Cellular Physiology</title>
<title type="short">J. Cell. Physiol.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="10">
<doi origin="wiley" registered="yes">10.1002/jcp.v149:1</doi>
<numberingGroup>
<numbering type="journalVolume" number="149">149</numbering>
<numbering type="journalIssue">1</numbering>
</numberingGroup>
<coverDate startDate="1991-10">October 1991</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="8" status="forIssue">
<doi origin="wiley" registered="yes">10.1002/jcp.1041490108</doi>
<idGroup>
<id type="unit" value="JCP1041490108"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="10"></count>
</countGroup>
<titleGroup>
<title type="articleCategory">Article</title>
<title type="tocHeading1">Articles</title>
</titleGroup>
<copyright ownership="publisher">Copyright © 1991 Wiley‐Liss, Inc.</copyright>
<eventGroup>
<event type="manuscriptReceived" date="1991-03-05"></event>
<event type="manuscriptAccepted" date="1991-05-08"></event>
<event type="firstOnline" date="2005-02-04"></event>
<event type="publishedOnlineFinalForm" date="2005-02-04"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-05"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-30"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-24"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst">50</numbering>
<numbering type="pageLast">59</numbering>
</numberingGroup>
<correspondenceTo>Department of Cell Biology, New York University Medical Center, 550 First Avenue, New York, NY 10076</correspondenceTo>
<linkGroup>
<link type="toTypesetVersion" href="file:JCP.JCP1041490108.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<countGroup>
<count type="figureTotal" number="7"></count>
<count type="tableTotal" number="1"></count>
<count type="referenceTotal" number="52"></count>
</countGroup>
<titleGroup>
<title type="main" xml:lang="en">Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects</title>
<title type="short" xml:lang="en">VASCULOTROPIN EFFECT ON HUVE CELLS</title>
</titleGroup>
<creators>
<creator xml:id="au1" creatorRole="author" affiliationRef="#af1" currentRef="#curr1" corresponding="yes">
<personName>
<givenNames>A.</givenNames>
<familyName>Bikfalvi</familyName>
</personName>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>C.</givenNames>
<familyName>Sauzeau</familyName>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af2" currentRef="#curr2">
<personName>
<givenNames>H.</givenNames>
<familyName>Moukadiri</familyName>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>J.</givenNames>
<familyName>Maclouf</familyName>
</personName>
</creator>
<creator xml:id="au5" creatorRole="author" affiliationRef="#af3">
<personName>
<givenNames>N.</givenNames>
<familyName>Busso</familyName>
</personName>
</creator>
<creator xml:id="au6" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>M.</givenNames>
<familyName>Bryckaert</familyName>
</personName>
</creator>
<creator xml:id="au7" creatorRole="author" affiliationRef="#af2" currentRef="#curr2">
<personName>
<givenNames>J.</givenNames>
<familyName>Plouet</familyName>
</personName>
</creator>
<creator xml:id="au8" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>G.</givenNames>
<familyName>Tobelem</familyName>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="af1" countryCode="FR" type="organization">
<unparsedAffiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="FR" type="organization">
<unparsedAffiliation>INSERM U 86, Centre des Cordeliers, 75006 Paris, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af3" countryCode="FR" type="organization">
<unparsedAffiliation>Laboratoires Glaxo, 91940 Les Ulis, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="curr1" countryCode="US">
<unparsedAffiliation>Department of Cell Biology, New York University Medical Center, 550 First Avenue, New York, NY 10076</unparsedAffiliation>
</affiliation>
<affiliation xml:id="curr2" countryCode="FR">
<unparsedAffiliation>ATIP, Centre de Recherches en Biochimie et Genetique Cellulaire, 114 route de Narbonne, 3100 Toulouse, France</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<abstractGroup>
<abstract type="main" xml:lang="en">
<title type="main">Abstract</title>
<p>Vasculotropin/vascular endothelial cell growth factor (VAS/VEGF) is a newly purified growth factor with a unique specificity for vascular endothelial cells. We have investigated the interactions of VAS/VEGF with human umbilical vein endothelial cells (HUVE cells).
<sup>125</sup>
I‐VAS/VEGF was bound to HUVE cells in a saturable manner with a half‐maximum binding at 2.8 ng/ml. Scatchard analysis did show two classes of high‐affinity binding sites. The first class displayed a dissociation constant of 9 pM with 500 sites/cell. The dissociation constant and the number of binding sites of the second binding class were variable for different HUVE cell cultures (K
<sub>D</sub>
= 179 ± 101 pM, 5,850 ± 2,950 sites/cell). Half‐maximal inhibition of
<sup>125</sup>
I‐VAS/VEGF occurred with a threefold excess of unlabeled ligand. Basic fibroblast growth factor (bFGF) and heparin did not compete with
<sup>125</sup>
I‐VAS/VEGF binding. In contrast, suramin and protamin sulfate completely displaced
<sup>125</sup>
I‐VAS/VEGF binding from HUVE cells. VAS/VEGF was shown to be internalized in HUVE cells. Maximum internalization (55% of total cell‐associated radioactivity) was observed after 30 min.
<sup>125</sup>
I‐VAS/VEGF was completely degraded 2–3 hr after binding. At 3 hr, the trichloroacetic acid (TCA)‐soluble radioactivity accumulated in the medium was 60% of the total radioactivity released by HUVE cells. No degradation fragment of
<sup>125</sup>
I‐VAS/VEGF was observed. Chloroquine completely inhibited degradation. VAS/VEGF was able to induce angiogenesis in vitro in HUVE cells. However, it did not significantly modulate urokinase‐type plasminogen activator (u‐PA), tissue‐type plasminogen activator (t‐PA), plasminogen activator inhibitor (PAI‐1), and tissue factor (TF). Prostacyclin production was only stimulated at very high VAS/VEGF concentrations. Taken together, these results indicate that VAS/VEGF might be a potent inducer of neovascularization resulting from a direct interaction with endothelial cells. The angiogenic activity seems to be independent of the plasminogen activator or inhibitor system.</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>VASCULOTROPIN EFFECT ON HUVE CELLS</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects</title>
</titleInfo>
<name type="personal">
<namePart type="given">A.</namePart>
<namePart type="family">Bikfalvi</namePart>
<affiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</affiliation>
<affiliation>Current Address: Department of Cell Biology, New York University Medical Center, 550 First Avenue, New York, NY 10076</affiliation>
<affiliation>Correspondence address: Department of Cell Biology, New York University Medical Center, 550 First Avenue, New York, NY 10076</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">C.</namePart>
<namePart type="family">Sauzeau</namePart>
<affiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">H.</namePart>
<namePart type="family">Moukadiri</namePart>
<affiliation>INSERM U 86, Centre des Cordeliers, 75006 Paris, France</affiliation>
<affiliation>Current Address: ATIP, Centre de Recherches en Biochimie et Genetique Cellulaire, 114 route de Narbonne, 3100 Toulouse, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Maclouf</namePart>
<affiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">N.</namePart>
<namePart type="family">Busso</namePart>
<affiliation>Laboratoires Glaxo, 91940 Les Ulis, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M.</namePart>
<namePart type="family">Bryckaert</namePart>
<affiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Plouet</namePart>
<affiliation>INSERM U 86, Centre des Cordeliers, 75006 Paris, France</affiliation>
<affiliation>Current Address: ATIP, Centre de Recherches en Biochimie et Genetique Cellulaire, 114 route de Narbonne, 3100 Toulouse, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">G.</namePart>
<namePart type="family">Tobelem</namePart>
<affiliation>INSERM U 150, Hopital Lariboisière, 75010 Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre>
<originInfo>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place>
<placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">1991-10</dateIssued>
<dateCaptured encoding="w3cdtf">1991-03-05</dateCaptured>
<dateValid encoding="w3cdtf">1991-05-08</dateValid>
<copyrightDate encoding="w3cdtf">1991</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<extent unit="figures">7</extent>
<extent unit="tables">1</extent>
<extent unit="references">52</extent>
</physicalDescription>
<abstract lang="en">Vasculotropin/vascular endothelial cell growth factor (VAS/VEGF) is a newly purified growth factor with a unique specificity for vascular endothelial cells. We have investigated the interactions of VAS/VEGF with human umbilical vein endothelial cells (HUVE cells). 125I‐VAS/VEGF was bound to HUVE cells in a saturable manner with a half‐maximum binding at 2.8 ng/ml. Scatchard analysis did show two classes of high‐affinity binding sites. The first class displayed a dissociation constant of 9 pM with 500 sites/cell. The dissociation constant and the number of binding sites of the second binding class were variable for different HUVE cell cultures (KD = 179 ± 101 pM, 5,850 ± 2,950 sites/cell). Half‐maximal inhibition of 125I‐VAS/VEGF occurred with a threefold excess of unlabeled ligand. Basic fibroblast growth factor (bFGF) and heparin did not compete with 125I‐VAS/VEGF binding. In contrast, suramin and protamin sulfate completely displaced 125I‐VAS/VEGF binding from HUVE cells. VAS/VEGF was shown to be internalized in HUVE cells. Maximum internalization (55% of total cell‐associated radioactivity) was observed after 30 min. 125I‐VAS/VEGF was completely degraded 2–3 hr after binding. At 3 hr, the trichloroacetic acid (TCA)‐soluble radioactivity accumulated in the medium was 60% of the total radioactivity released by HUVE cells. No degradation fragment of 125I‐VAS/VEGF was observed. Chloroquine completely inhibited degradation. VAS/VEGF was able to induce angiogenesis in vitro in HUVE cells. However, it did not significantly modulate urokinase‐type plasminogen activator (u‐PA), tissue‐type plasminogen activator (t‐PA), plasminogen activator inhibitor (PAI‐1), and tissue factor (TF). Prostacyclin production was only stimulated at very high VAS/VEGF concentrations. Taken together, these results indicate that VAS/VEGF might be a potent inducer of neovascularization resulting from a direct interaction with endothelial cells. The angiogenic activity seems to be independent of the plasminogen activator or inhibitor system.</abstract>
<relatedItem type="host">
<titleInfo>
<title>Journal of Cellular Physiology</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>J. Cell. Physiol.</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<subject>
<genre>article-category</genre>
<topic>Article</topic>
<topic>Articles</topic>
</subject>
<identifier type="ISSN">0021-9541</identifier>
<identifier type="eISSN">1097-4652</identifier>
<identifier type="DOI">10.1002/(ISSN)1097-4652</identifier>
<identifier type="PublisherID">JCP</identifier>
<part>
<date>1991</date>
<detail type="volume">
<caption>vol.</caption>
<number>149</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>1</number>
</detail>
<extent unit="pages">
<start>50</start>
<end>59</end>
<total>10</total>
</extent>
</part>
</relatedItem>
<relatedItem type="references" displayLabel="cit1">
<titleInfo>
<title>Interleukin‐1 (IL‐1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">M. P.</namePart>
<namePart type="family">Bevilacqua</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J. S.</namePart>
<namePart type="family">Pober</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">G. R.</namePart>
<namePart type="family">Majeau</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R. S.</namePart>
<namePart type="family">Cotran</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M. A.</namePart>
<namePart type="family">Gim‐brone</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S., and Gim‐brone, M. A., (1984) Interleukin‐1 (IL‐1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J. Exp. Med., 160:618–623.</note>
<part>
<date>1984</date>
<detail type="volume">
<caption>vol.</caption>
<number>160</number>
</detail>
<extent unit="pages">
<start>618</start>
<end>623</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Exp. Med.</title>
</titleInfo>
<part>
<date>1984</date>
<detail type="volume">
<caption>vol.</caption>
<number>160</number>
</detail>
<extent unit="pages">
<start>618</start>
<end>623</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit2">
<titleInfo>
<title>Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin</title>
</titleInfo>
<name type="personal">
<namePart type="given">M. P.</namePart>
<namePart type="family">Bevilacqua</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J. S.</namePart>
<namePart type="family">Pober</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">G. R.</namePart>
<namePart type="family">Majeau</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">W.</namePart>
<namePart type="family">Fiers</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R. S.</namePart>
<namePart type="family">Cotran</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M. A.</namePart>
<namePart type="family">Gimbrone</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Fiers, W., Cotran, R. S., and Gimbrone, M. A., (1986) Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin. Proc. Natl. Acad. Sci. USA, 83:4553–4537.</note>
<part>
<date>1986</date>
<detail type="volume">
<caption>vol.</caption>
<number>83</number>
</detail>
<extent unit="pages">
<start>4553</start>
<end>4537</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Proc. Natl. Acad. Sci. USA</title>
</titleInfo>
<part>
<date>1986</date>
<detail type="volume">
<caption>vol.</caption>
<number>83</number>
</detail>
<extent unit="pages">
<start>4553</start>
<end>4537</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit3">
<titleInfo>
<title>Binding, internalization and degradation of basic fibroblast growth factor in human microvascular endothelial cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">A.</namePart>
<namePart type="family">Bikfalvi</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">E.</namePart>
<namePart type="family">Dupuy</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A. L.</namePart>
<namePart type="family">Inyang</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">N.</namePart>
<namePart type="family">Fayein</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">G.</namePart>
<namePart type="family">Leseche</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Y.</namePart>
<namePart type="family">Courtois</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Bikfalvi, A., Dupuy, E., Inyang, A. L., Fayein, N., Leseche, G., and Courtois, Y., (1989) Binding, internalization and degradation of basic fibroblast growth factor in human microvascular endothelial cells. Exp. Cell Res., 181:75–84.</note>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>181</number>
</detail>
<extent unit="pages">
<start>75</start>
<end>84</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Exp. Cell Res.</title>
</titleInfo>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>181</number>
</detail>
<extent unit="pages">
<start>75</start>
<end>84</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit4">
<titleInfo>
<title>Interleukin‐1 stimulates prostacy‐clin production in cultured human endothelial cells by increasing arachidonic acid mobilization and conversion</title>
</titleInfo>
<name type="personal">
<namePart type="given">F.</namePart>
<namePart type="family">Brevario</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">P.</namePart>
<namePart type="family">Proserpio</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">F.</namePart>
<namePart type="family">Bertocchi</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M. G.</namePart>
<namePart type="family">Lampugnani</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A.</namePart>
<namePart type="family">Monto‐vani</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">E.</namePart>
<namePart type="family">Dejana</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Brevario, F., Proserpio, P., Bertocchi, F., Lampugnani, M. G., Monto‐vani, A., and Dejana, E., (1990) Interleukin‐1 stimulates prostacy‐clin production in cultured human endothelial cells by increasing arachidonic acid mobilization and conversion. Arteriosclerosis 10(1):129–134.</note>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>10</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>1</number>
</detail>
<extent unit="pages">
<start>129</start>
<end>134</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Arteriosclerosis</title>
</titleInfo>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>10</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>1</number>
</detail>
<extent unit="pages">
<start>129</start>
<end>134</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit5">
<titleInfo>
<title>Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">R. J.</namePart>
<namePart type="family">Coffrey</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">E.</namePart>
<namePart type="family">Leof</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">G. D.</namePart>
<namePart type="family">Shipley</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">H.</namePart>
<namePart type="family">Moses</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Coffrey, R. J., Leof, E., Shipley, G. D., and Moses, H., (1987) Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cells. J. Cell. Physiol., 132:143–148.</note>
<part>
<date>1987</date>
<detail type="volume">
<caption>vol.</caption>
<number>132</number>
</detail>
<extent unit="pages">
<start>143</start>
<end>148</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Cell. Physiol.</title>
</titleInfo>
<part>
<date>1987</date>
<detail type="volume">
<caption>vol.</caption>
<number>132</number>
</detail>
<extent unit="pages">
<start>143</start>
<end>148</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit6">
<titleInfo>
<title>Amino acid and cDNA sequence of a vascular endothelial cell mitogen which is homologous to platelet derived‐growth factor</title>
</titleInfo>
<name type="personal">
<namePart type="given">G.</namePart>
<namePart type="family">Conn</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M. L.</namePart>
<namePart type="family">Bayne</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">P. W.</namePart>
<namePart type="family">Soderman</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">P. W.</namePart>
<namePart type="family">Kxok</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">K. A.</namePart>
<namePart type="family">Sullivan</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">T. M.</namePart>
<namePart type="family">Palisi</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D. A.</namePart>
<namePart type="family">Hope</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">K. A.</namePart>
<namePart type="family">Thomas</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Conn, G., Bayne, M. L., Soderman, P. W., Kxok, P. W. Sullivan, K. A., Palisi, T. M., Hope, D. A., and Thomas, K. A., (1990) Amino acid and cDNA sequence of a vascular endothelial cell mitogen which is homologous to platelet derived‐growth factor. Proc. Natl. Acad. Sci. USA, 87:2628–2632.</note>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>87</number>
</detail>
<extent unit="pages">
<start>2628</start>
<end>2632</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Proc. Natl. Acad. Sci. USA</title>
</titleInfo>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>87</number>
</detail>
<extent unit="pages">
<start>2628</start>
<end>2632</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit7">
<titleInfo>
<title>Purification of a glycoprotein vascular endothelial cell mitogen from rat‐glioma derived cell line</title>
</titleInfo>
<name type="personal">
<namePart type="given">G.</namePart>
<namePart type="family">Conn</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D. G.</namePart>
<namePart type="family">Soderman</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M. T.</namePart>
<namePart type="family">Schaeffer</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M.</namePart>
<namePart type="family">Wile</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">V. B.</namePart>
<namePart type="family">Hatcher</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">K. A.</namePart>
<namePart type="family">Thomas</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Conn, G., Soderman, D. G., Schaeffer, M. T., Wile, M., Hatcher, V. B., and Thomas, K. A., (1989) Purification of a glycoprotein vascular endothelial cell mitogen from rat‐glioma derived cell line. Proc. Natl. Acad. Sci. USA, 87:1323–1327.</note>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>87</number>
</detail>
<extent unit="pages">
<start>1323</start>
<end>1327</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Proc. Natl. Acad. Sci. USA</title>
</titleInfo>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>87</number>
</detail>
<extent unit="pages">
<start>1323</start>
<end>1327</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit8">
<titleInfo>
<title>Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis</title>
</titleInfo>
<name type="personal">
<namePart type="given">D. T.</namePart>
<namePart type="family">Connolly</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Heuvelman</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R.</namePart>
<namePart type="family">Nelson</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J. V.</namePart>
<namePart type="family">Olander</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">B. L.</namePart>
<namePart type="family">Eppler</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J. J.</namePart>
<namePart type="family">Delfino</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">N. R.</namePart>
<namePart type="family">Siegel</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R. M.</namePart>
<namePart type="family">Leimgruber</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Feder</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Connolly, D. T., Heuvelman, D., Nelson, R., Olander, J. V., Eppler, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., and Feder, J., (1989a) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest., 84:1470–1478.</note>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>84</number>
</detail>
<extent unit="pages">
<start>1470</start>
<end>1478</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Clin. Invest.</title>
</titleInfo>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>84</number>
</detail>
<extent unit="pages">
<start>1470</start>
<end>1478</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit9">
<titleInfo>
<title>Human vascular permeability factor</title>
</titleInfo>
<name type="personal">
<namePart type="given">D. T.</namePart>
<namePart type="family">Connolly</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J. V.</namePart>
<namePart type="family">Olander</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Heuvelman</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R.</namePart>
<namePart type="family">Nelson</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R.</namePart>
<namePart type="family">Monsell</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">N.</namePart>
<namePart type="family">Siegel</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">B. L.</namePart>
<namePart type="family">Haymore</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R.</namePart>
<namePart type="family">Leimgruber</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">N.</namePart>
<namePart type="family">Feder</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Connolly, D. T., Olander, J. V., Heuvelman, D., Nelson, R., Monsell, R., Siegel, N., Haymore, B. L., Leimgruber, R., and Feder, N., (1989) Human vascular permeability factor. J. Biol. Chem., 264:2017–2024.</note>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>264</number>
</detail>
<extent unit="pages">
<start>2017</start>
<end>2024</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Biol. Chem.</title>
</titleInfo>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>264</number>
</detail>
<extent unit="pages">
<start>2017</start>
<end>2024</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit10">
<titleInfo>
<title>Interleukin 1 is an autocrine regulator of human endothelial cell growth</title>
</titleInfo>
<name type="personal">
<namePart type="given">F.</namePart>
<namePart type="family">Cozzolino</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M.</namePart>
<namePart type="family">Torcia</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Aldinucci</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M.</namePart>
<namePart type="family">Ziche</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">F.</namePart>
<namePart type="family">Almerigogna</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Bani</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Stern</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Cozzolino, F., Torcia, M., Aldinucci, D., Ziche, M., Almerigogna, F., Bani, D., and Stern, D., (1990) Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc. Natl. Acad. Sci. USA, 87:6487–6491.</note>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>87</number>
</detail>
<extent unit="pages">
<start>6487</start>
<end>6491</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Proc. Natl. Acad. Sci. USA</title>
</titleInfo>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>87</number>
</detail>
<extent unit="pages">
<start>6487</start>
<end>6491</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit11">
<titleInfo>
<title>Pituitary follicular cells secrete a novel heparin‐binding growth factor specific for vascular endothelial cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">N.</namePart>
<namePart type="family">Ferrara</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">W. J.</namePart>
<namePart type="family">Henzel</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ferrara, N., and Henzel, W. J., (1989) Pituitary follicular cells secrete a novel heparin‐binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun., 161:851–858.</note>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>161</number>
</detail>
<extent unit="pages">
<start>851</start>
<end>858</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Biochem. Biophys. Res. Commun.</title>
</titleInfo>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>161</number>
</detail>
<extent unit="pages">
<start>851</start>
<end>858</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit12">
<titleInfo>
<title>Tumor necrosis factor type β, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo</title>
</titleInfo>
<name type="personal">
<namePart type="given">M.</namePart>
<namePart type="family">Frater‐Schroder</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">W.</namePart>
<namePart type="family">Risau</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R.</namePart>
<namePart type="family">Hallman</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">P.</namePart>
<namePart type="family">Gautschi</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">P.</namePart>
<namePart type="family">Bohlen</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Frater‐Schroder, M., Risau, W., Hallman, R., Gautschi, P., and Bohlen, P., (1987) Tumor necrosis factor type β, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA, 84:5277–5281.</note>
<part>
<date>1987</date>
<detail type="volume">
<caption>vol.</caption>
<number>84</number>
</detail>
<extent unit="pages">
<start>5277</start>
<end>5281</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Proc. Natl. Acad. Sci. USA</title>
</titleInfo>
<part>
<date>1987</date>
<detail type="volume">
<caption>vol.</caption>
<number>84</number>
</detail>
<extent unit="pages">
<start>5277</start>
<end>5281</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit13">
<titleInfo>
<title>Injury‐induced release of basic fibroblast growth factor from bovine aortic endothelium</title>
</titleInfo>
<name type="personal">
<namePart type="given">C.</namePart>
<namePart type="family">Gadjusek</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">S.</namePart>
<namePart type="family">Carbon</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Gadjusek, C., and Carbon, S., (1989) Injury‐induced release of basic fibroblast growth factor from bovine aortic endothelium. J. Cell. Physiol., 139:570–579.</note>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>139</number>
</detail>
<extent unit="pages">
<start>570</start>
<end>579</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Cell. Physiol.</title>
</titleInfo>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>139</number>
</detail>
<extent unit="pages">
<start>570</start>
<end>579</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit14">
<titleInfo>
<title>Isolation and characterization of a endo thelial cell mitogen produced by pituitary‐derived folliculo‐stellated cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Gospodarowicz</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Abraham</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Schilling</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Gospodarowicz, D., Abraham, J., and Schilling, J., (1989) Isolation and characterization of a endo thelial cell mitogen produced by pituitary‐derived folliculo‐stellated cells. Proc. Natl. Acad. Sci. USA, 6:7311–7315.</note>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>6</number>
</detail>
<extent unit="pages">
<start>7311</start>
<end>7315</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Proc. Natl. Acad. Sci. USA</title>
</titleInfo>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>6</number>
</detail>
<extent unit="pages">
<start>7311</start>
<end>7315</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit15">
<titleInfo>
<title>125 J‐labeled growth hormone of high specific radioactivity</title>
</titleInfo>
<name type="personal">
<namePart type="given">F. C.</namePart>
<namePart type="family">Greenwood</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">W. H.</namePart>
<namePart type="family">Hunter</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J. S.</namePart>
<namePart type="family">Glover</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Greenwood, F. C., Hunter, W. H., and Glover, J. S., (1963) 125 J‐labeled growth hormone of high specific radioactivity. Biochem. J., 89:114–123.</note>
<part>
<date>1963</date>
<detail type="volume">
<caption>vol.</caption>
<number>89</number>
</detail>
<extent unit="pages">
<start>114</start>
<end>123</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Biochem. J.</title>
</titleInfo>
<part>
<date>1963</date>
<detail type="volume">
<caption>vol.</caption>
<number>89</number>
</detail>
<extent unit="pages">
<start>114</start>
<end>123</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit16">
<titleInfo>
<title>Dansylcadaverine inhibits internalization of 125 I‐Epidermal Growth Factor in Balb 3T3 cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">H. X.</namePart>
<namePart type="family">Haigler</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">F. R.</namePart>
<namePart type="family">Maxfield</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M. C.</namePart>
<namePart type="family">Willingham</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">I.</namePart>
<namePart type="family">Pastan</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Haigler, H. X., Maxfield, F. R., Willingham, M. C., and Pastan, I., (1980) Dansylcadaverine inhibits internalization of 125 I‐Epidermal Growth Factor in Balb 3T3 cells. Biol. Chem., 255:1239–1241.</note>
<part>
<date>1980</date>
<detail type="volume">
<caption>vol.</caption>
<number>255</number>
</detail>
<extent unit="pages">
<start>1239</start>
<end>1241</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Biol. Chem.</title>
</titleInfo>
<part>
<date>1980</date>
<detail type="volume">
<caption>vol.</caption>
<number>255</number>
</detail>
<extent unit="pages">
<start>1239</start>
<end>1241</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit17">
<titleInfo>
<title>Stimulation of cell growth and inhibition of prostacyclin production by herparin in human umbilical vein endothelial cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">N.</namePart>
<namePart type="family">Hasegawa</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M.</namePart>
<namePart type="family">Yamamoto</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">K.</namePart>
<namePart type="family">Yamamoto</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Hasegawa, N., Yamamoto, M., and Yamamoto, K., (1988) Stimulation of cell growth and inhibition of prostacyclin production by herparin in human umbilical vein endothelial cells. J. Cell. Physiol., 137:603–607.</note>
<part>
<date>1988</date>
<detail type="volume">
<caption>vol.</caption>
<number>137</number>
</detail>
<extent unit="pages">
<start>603</start>
<end>607</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Cell. Physiol.</title>
</titleInfo>
<part>
<date>1988</date>
<detail type="volume">
<caption>vol.</caption>
<number>137</number>
</detail>
<extent unit="pages">
<start>603</start>
<end>607</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit18">
<titleInfo>
<title>Specific receptors for platelet derived growth factor on cells derived from connective tissue and glia</title>
</titleInfo>
<name type="personal">
<namePart type="given">K.‐H.</namePart>
<namePart type="family">Heldin</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">B.</namePart>
<namePart type="family">Westermark</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A.</namePart>
<namePart type="family">Wasteson</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Heldin, K.‐H., Westermark, B., and Wasteson, A., (1981) Specific receptors for platelet derived growth factor on cells derived from connective tissue and glia. Proc. Natl. Acad. Sci. USA, 78:3664–3668.</note>
<part>
<date>1981</date>
<detail type="volume">
<caption>vol.</caption>
<number>78</number>
</detail>
<extent unit="pages">
<start>3664</start>
<end>3668</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Proc. Natl. Acad. Sci. USA</title>
</titleInfo>
<part>
<date>1981</date>
<detail type="volume">
<caption>vol.</caption>
<number>78</number>
</detail>
<extent unit="pages">
<start>3664</start>
<end>3668</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit19">
<titleInfo>
<title>Culture of human endothelial cells derived from umbilical veins</title>
</titleInfo>
<name type="personal">
<namePart type="given">E. A.</namePart>
<namePart type="family">Jaffe</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R. L.</namePart>
<namePart type="family">Nachman</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">C. G.</namePart>
<namePart type="family">Becker</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">C. R.</namePart>
<namePart type="family">Minick</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Jaffe, E. A., Nachman, R. L., Becker, C. G., and Minick, C. R., (1973) Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest., 52:2745–2756.</note>
<part>
<date>1973</date>
<detail type="volume">
<caption>vol.</caption>
<number>52</number>
</detail>
<extent unit="pages">
<start>2745</start>
<end>2756</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Clin. Invest.</title>
</titleInfo>
<part>
<date>1973</date>
<detail type="volume">
<caption>vol.</caption>
<number>52</number>
</detail>
<extent unit="pages">
<start>2745</start>
<end>2756</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit20">
<titleInfo>
<title>Vascular permeability factor, an endot‐helial cell mitogen related to PDGF</title>
</titleInfo>
<name type="personal">
<namePart type="given">P. J.</namePart>
<namePart type="family">Keck</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">S. D.</namePart>
<namePart type="family">Hauser</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">G.</namePart>
<namePart type="family">Krivi</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">K.</namePart>
<namePart type="family">Sanzo</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">T.</namePart>
<namePart type="family">Warren</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Feder</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D. T.</namePart>
<namePart type="family">Connolly</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., and Connolly, D. T., (1989) Vascular permeability factor, an endot‐helial cell mitogen related to PDGF. Science, 246:1309–1312.</note>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>246</number>
</detail>
<extent unit="pages">
<start>1309</start>
<end>1312</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Science</title>
</titleInfo>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>246</number>
</detail>
<extent unit="pages">
<start>1309</start>
<end>1312</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit21">
<titleInfo>
<title>Ligand affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor</title>
</titleInfo>
<name type="personal">
<namePart type="given">M. C.</namePart>
<namePart type="family">Kieffer</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J. C.</namePart>
<namePart type="family">Stephans</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">K.</namePart>
<namePart type="family">Crawford</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">K.</namePart>
<namePart type="family">Okino</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">P.</namePart>
<namePart type="family">Barr</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kieffer, M. C., Stephans, J. C., Crawford, K., Okino, K., and Barr, P., (1990) Ligand affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA, 87:6984–6989.</note>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>87</number>
</detail>
<extent unit="pages">
<start>6984</start>
<end>6989</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Proc. Natl. Acad. Sci. USA</title>
</titleInfo>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>87</number>
</detail>
<extent unit="pages">
<start>6984</start>
<end>6989</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit22">
<titleInfo>
<title>Stimulation of endothelial cell prostacyclin release by retina‐derived growth factors</title>
</titleInfo>
<name type="personal">
<namePart type="given">L.</namePart>
<namePart type="family">Kuwashima</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Greaber</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">B.</namePart>
<namePart type="family">Glaser</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Kuwashima, L., Greaber, J., and Glaser, B., (1988) Stimulation of endothelial cell prostacyclin release by retina‐derived growth factors. Invest. Ophthalmol. Vis. Sci., 29:1213–1220.</note>
<part>
<date>1988</date>
<detail type="volume">
<caption>vol.</caption>
<number>29</number>
</detail>
<extent unit="pages">
<start>1213</start>
<end>1220</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Invest. Ophthalmol. Vis. Sci.</title>
</titleInfo>
<part>
<date>1988</date>
<detail type="volume">
<caption>vol.</caption>
<number>29</number>
</detail>
<extent unit="pages">
<start>1213</start>
<end>1220</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit23">
<titleInfo>
<title>Cleavage of structural proteins during the assembly of the head of bacteriophage T4</title>
</titleInfo>
<name type="personal">
<namePart type="given">V. K.</namePart>
<namePart type="family">Laemmli</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Laemmli, V. K., (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227:680–685.</note>
<part>
<date>1970</date>
<detail type="volume">
<caption>vol.</caption>
<number>227</number>
</detail>
<extent unit="pages">
<start>680</start>
<end>685</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Nature</title>
</titleInfo>
<part>
<date>1970</date>
<detail type="volume">
<caption>vol.</caption>
<number>227</number>
</detail>
<extent unit="pages">
<start>680</start>
<end>685</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit24">
<titleInfo>
<title>Vascular endothelial cell growth factor is a secreted angigenic mitogen</title>
</titleInfo>
<name type="personal">
<namePart type="given">D. W.</namePart>
<namePart type="family">Leung</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">G.</namePart>
<namePart type="family">Cachianes</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">W. J.</namePart>
<namePart type="family">Kuang</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D. W.</namePart>
<namePart type="family">Goedel</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">N.</namePart>
<namePart type="family">Ferrara</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Leung, D. W., Cachianes, G., Kuang, W. J., Goedel, D. W., and Ferrara, N., (1989) Vascular endothelial cell growth factor is a secreted angigenic mitogen. Science, 246:1306–1312.</note>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>246</number>
</detail>
<extent unit="pages">
<start>1306</start>
<end>1312</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Science</title>
</titleInfo>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>246</number>
</detail>
<extent unit="pages">
<start>1306</start>
<end>1312</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit25">
<titleInfo>
<title>An endothelial growth factor from the mouse neuroblastoma cell line</title>
</titleInfo>
<name type="personal">
<namePart type="given">A. L.</namePart>
<namePart type="family">Levy</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R.</namePart>
<namePart type="family">Tamargo</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">H.</namePart>
<namePart type="family">Brem</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Nathans</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Levy, A. L., Tamargo, R., Brem, H., and Nathans, D., (1990) An endothelial growth factor from the mouse neuroblastoma cell line. Growth Factors, 2:9–19.</note>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages">
<start>9</start>
<end>19</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Growth Factors</title>
</titleInfo>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>2</number>
</detail>
<extent unit="pages">
<start>9</start>
<end>19</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit26">
<titleInfo>
<title>Phenotypic modulation of endothelial cells by transforming growth factor beta depends upon the composition and organization of the extracellular matrix</title>
</titleInfo>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Madri</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">B. M.</namePart>
<namePart type="family">Pratt</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A.</namePart>
<namePart type="family">Tucker</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Madri, J., Pratt, B. M., and Tucker, A., (1988) Phenotypic modulation of endothelial cells by transforming growth factor beta depends upon the composition and organization of the extracellular matrix. J. Cell Biol., 106:1375–1384.</note>
<part>
<date>1988</date>
<detail type="volume">
<caption>vol.</caption>
<number>106</number>
</detail>
<extent unit="pages">
<start>1375</start>
<end>1384</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Cell Biol.</title>
</titleInfo>
<part>
<date>1988</date>
<detail type="volume">
<caption>vol.</caption>
<number>106</number>
</detail>
<extent unit="pages">
<start>1375</start>
<end>1384</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit27">
<titleInfo>
<title>Growth factors are released by mechanically wounded endothelial cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">P. L.</namePart>
<namePart type="family">McNeil</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">L.</namePart>
<namePart type="family">Muthukrishnan</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">E.</namePart>
<namePart type="family">Warder</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">P.</namePart>
<namePart type="family">D'Armore</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">McNeil, P. L., Muthukrishnan, L., Warder, E., and D'Armore, P., (1989) Growth factors are released by mechanically wounded endothelial cells. J. Cell Biol., 109:811–822.</note>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>109</number>
</detail>
<extent unit="pages">
<start>811</start>
<end>822</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Cell Biol.</title>
</titleInfo>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>109</number>
</detail>
<extent unit="pages">
<start>811</start>
<end>822</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit28">
<titleInfo>
<title>Internalization and limited processing of basic fibroblast growth factor on Chinese hamster lung fibroblast</title>
</titleInfo>
<name type="personal">
<namePart type="given">M.</namePart>
<namePart type="family">Moenner</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">L.</namePart>
<namePart type="family">Gannoun‐Zaki</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Badet</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Barritault</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Moenner, M., Gannoun‐Zaki, L., Badet, J., and Barritault, D., (1989) Internalization and limited processing of basic fibroblast growth factor on Chinese hamster lung fibroblast. Growth Factors, 1:115–123.</note>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages">
<start>115</start>
<end>123</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Growth Factors</title>
</titleInfo>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>1</number>
</detail>
<extent unit="pages">
<start>115</start>
<end>123</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit29">
<titleInfo>
<title>Tumor promoting phorbol ester induces angiogenesis in vitro</title>
</titleInfo>
<name type="personal">
<namePart type="given">R.</namePart>
<namePart type="family">Montesano</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">L.</namePart>
<namePart type="family">Orci</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Montesano, R., and Orci, L., (1985) Tumor promoting phorbol ester induces angiogenesis in vitro. Cell, 42:469–487.</note>
<part>
<date>1985</date>
<detail type="volume">
<caption>vol.</caption>
<number>42</number>
</detail>
<extent unit="pages">
<start>469</start>
<end>487</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Cell</title>
</titleInfo>
<part>
<date>1985</date>
<detail type="volume">
<caption>vol.</caption>
<number>42</number>
</detail>
<extent unit="pages">
<start>469</start>
<end>487</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit30">
<titleInfo>
<title>Basic fibroblast growth factor induces angiogenesis in vitro</title>
</titleInfo>
<name type="personal">
<namePart type="given">R.</namePart>
<namePart type="family">Montesano</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J. D.</namePart>
<namePart type="family">Vassalli</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A.</namePart>
<namePart type="family">Baird</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R.</namePart>
<namePart type="family">Guillemin</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">L.</namePart>
<namePart type="family">Orci</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Montesano, R., Vassalli, J. D., Baird, A., Guillemin, R., and Orci, L., (1986) Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. USA, 84:7297–7301.</note>
<part>
<date>1986</date>
<detail type="volume">
<caption>vol.</caption>
<number>84</number>
</detail>
<extent unit="pages">
<start>7297</start>
<end>7301</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Proc. Natl. Acad. Sci. USA</title>
</titleInfo>
<part>
<date>1986</date>
<detail type="volume">
<caption>vol.</caption>
<number>84</number>
</detail>
<extent unit="pages">
<start>7297</start>
<end>7301</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit31">
<titleInfo>
<title>Phorbol esters induce angiogenesis in vitro from large vessel endothelial cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">R.</namePart>
<namePart type="family">Montesano</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">L.</namePart>
<namePart type="family">Orci</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Montesano, R., and Orci, L., (1987) Phorbol esters induce angiogenesis in vitro from large vessel endothelial cells. J. Cell. Physiol., 130:284–291.</note>
<part>
<date>1987</date>
<detail type="volume">
<caption>vol.</caption>
<number>130</number>
</detail>
<extent unit="pages">
<start>284</start>
<end>291</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Cell. Physiol.</title>
</titleInfo>
<part>
<date>1987</date>
<detail type="volume">
<caption>vol.</caption>
<number>130</number>
</detail>
<extent unit="pages">
<start>284</start>
<end>291</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit32">
<titleInfo>
<title>High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role of low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Moscatelli</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Moscatelli, D., (1987) High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role of low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J. Cell. Physiol., 131:123–130.</note>
<part>
<date>1987</date>
<detail type="volume">
<caption>vol.</caption>
<number>131</number>
</detail>
<extent unit="pages">
<start>123</start>
<end>130</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Cell. Physiol.</title>
</titleInfo>
<part>
<date>1987</date>
<detail type="volume">
<caption>vol.</caption>
<number>131</number>
</detail>
<extent unit="pages">
<start>123</start>
<end>130</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit33">
<titleInfo>
<title>Metabolism of receptor bound and matrix bound basic fibroblast growth factor by bovine capillary endothelial cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Moscatelli</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Moscatelli, D., (1988) Metabolism of receptor bound and matrix bound basic fibroblast growth factor by bovine capillary endothelial cells. J. Cell Biol., 107:753–759.</note>
<part>
<date>1988</date>
<detail type="volume">
<caption>vol.</caption>
<number>107</number>
</detail>
<extent unit="pages">
<start>753</start>
<end>759</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Cell Biol.</title>
</titleInfo>
<part>
<date>1988</date>
<detail type="volume">
<caption>vol.</caption>
<number>107</number>
</detail>
<extent unit="pages">
<start>753</start>
<end>759</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit34">
<titleInfo>
<title>Vascu‐lotropin, a new angiogenic growth factor</title>
</titleInfo>
<name type="personal">
<namePart type="given">H.</namePart>
<namePart type="family">Moukadiri</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">C.</namePart>
<namePart type="family">Favard</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">V.</namePart>
<namePart type="family">Praloran</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Plouet</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>other</genre>
<part>
<date>1990</date>
</part>
</relatedItem>
<relatedItem type="references" displayLabel="cit35">
<titleInfo>
<title>Protamin sulfate inhibits mitogenic activities of extracellular matrix and fibroblast growth factor, but potentiates that of epidermal growth factor</title>
</titleInfo>
<name type="personal">
<namePart type="given">G.</namePart>
<namePart type="family">Neufeld</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Gospodarowicz</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Neufeld, G., and Gospodarowicz, D., (1987) Protamin sulfate inhibits mitogenic activities of extracellular matrix and fibroblast growth factor, but potentiates that of epidermal growth factor. J. Cell. Physiol., 132:287–294.</note>
<part>
<date>1987</date>
<detail type="volume">
<caption>vol.</caption>
<number>132</number>
</detail>
<extent unit="pages">
<start>287</start>
<end>294</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Cell. Physiol.</title>
</titleInfo>
<part>
<date>1987</date>
<detail type="volume">
<caption>vol.</caption>
<number>132</number>
</detail>
<extent unit="pages">
<start>287</start>
<end>294</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit36">
<titleInfo>
<title>Transforming growth factor beta 1 modulates basic fibroblast growth factor‐induced proteolytic and angiogenic properties of endothelial cells in vitro</title>
</titleInfo>
<name type="personal">
<namePart type="given">M. S.</namePart>
<namePart type="family">Pepper</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Belin</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R.</namePart>
<namePart type="family">Montesano</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">L.</namePart>
<namePart type="family">Orci</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.‐D.</namePart>
<namePart type="family">Vassalli</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Pepper, M. S., Belin, D., Montesano, R., Orci, L., and Vassalli, J.‐D., (1990) Transforming growth factor beta 1 modulates basic fibroblast growth factor‐induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol., 111:743–755.</note>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>111</number>
</detail>
<extent unit="pages">
<start>743</start>
<end>755</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Cell Biol.</title>
</titleInfo>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>111</number>
</detail>
<extent unit="pages">
<start>743</start>
<end>755</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit37">
<titleInfo>
<title>Vascular endothelial growth factor is expressed in rat corpus luteum</title>
</titleInfo>
<name type="personal">
<namePart type="given">H. S.</namePart>
<namePart type="family">Phillips</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Haines</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Leung</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">N.</namePart>
<namePart type="family">Ferrara</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Phillips, H. S., Haines, J., Leung, D., and Ferrara, N., (1990) Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology, 127:965–967.</note>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>127</number>
</detail>
<extent unit="pages">
<start>965</start>
<end>967</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Endocrinology</title>
</titleInfo>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>127</number>
</detail>
<extent unit="pages">
<start>965</start>
<end>967</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit38">
<titleInfo>
<title>Specific binding of vasculotropin to bovine brain capillary endothelial cells: description of a radioroceptor assay</title>
</titleInfo>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Plouet</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">H.</namePart>
<namePart type="family">Moukadiri</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Plouet, J., and Moukadiri, H., (1990a) Specific binding of vasculotropin to bovine brain capillary endothelial cells: description of a radioroceptor assay. Biochimie, 72:51–55.</note>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>72</number>
</detail>
<extent unit="pages">
<start>51</start>
<end>55</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Biochimie</title>
</titleInfo>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>72</number>
</detail>
<extent unit="pages">
<start>51</start>
<end>55</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit39">
<titleInfo>
<title>Characterization of the receptor of vasculotropin on bovine adrenal cortex derived capillary endot‐helial cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Plouet</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">H.</namePart>
<namePart type="family">Moukadiri</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Plouet, J., and Moukadiri, H., (1990b) Characterization of the receptor of vasculotropin on bovine adrenal cortex derived capillary endot‐helial cells. J. Biol. Chem., 265:22071–22074.</note>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>265</number>
</detail>
<extent unit="pages">
<start>22071</start>
<end>22074</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Biol. Chem.</title>
</titleInfo>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>265</number>
</detail>
<extent unit="pages">
<start>22071</start>
<end>22074</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit40">
<titleInfo>
<title>Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT‐20 cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Plouet</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Schilling</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Gospodarowicz</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Plouet, J., Schilling, J., and Gospodarowicz, D., (1989) Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT‐20 cells. EMBO J., 8:3801–3806.</note>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>8</number>
</detail>
<extent unit="pages">
<start>3801</start>
<end>3806</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>EMBO J.</title>
</titleInfo>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>8</number>
</detail>
<extent unit="pages">
<start>3801</start>
<end>3806</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit41">
<titleInfo>
<title>Enzyme immunoassay of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay</title>
</titleInfo>
<name type="personal">
<namePart type="given">P.</namePart>
<namePart type="family">Pradelles</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Grassi</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Maclouf</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Pradelles, P., Grassi, J., and Maclouf, J., (1985) Enzyme immunoassay of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal. Chem., 57:1170–1173.</note>
<part>
<date>1985</date>
<detail type="volume">
<caption>vol.</caption>
<number>57</number>
</detail>
<extent unit="pages">
<start>1170</start>
<end>1173</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Anal. Chem.</title>
</titleInfo>
<part>
<date>1985</date>
<detail type="volume">
<caption>vol.</caption>
<number>57</number>
</detail>
<extent unit="pages">
<start>1170</start>
<end>1173</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit42">
<titleInfo>
<title>The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">O.</namePart>
<namePart type="family">Saksela</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Moscatelli</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Rifkin</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Saksela, O., Moscatelli, D., and Rifkin, D., (1987) The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J. Cell Biol., 105:957–964.</note>
<part>
<date>1987</date>
<detail type="volume">
<caption>vol.</caption>
<number>105</number>
</detail>
<extent unit="pages">
<start>957</start>
<end>964</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Cell Biol.</title>
</titleInfo>
<part>
<date>1987</date>
<detail type="volume">
<caption>vol.</caption>
<number>105</number>
</detail>
<extent unit="pages">
<start>957</start>
<end>964</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit43">
<titleInfo>
<title>The attraction of proteins for small molecules and ions</title>
</titleInfo>
<name type="personal">
<namePart type="given">G.</namePart>
<namePart type="family">Scatchard</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Scatchard, G., (1948) The attraction of proteins for small molecules and ions. Ann. NY Acad. Sci., 51:660–672.</note>
<part>
<date>1948</date>
<detail type="volume">
<caption>vol.</caption>
<number>51</number>
</detail>
<extent unit="pages">
<start>660</start>
<end>672</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Ann. NY Acad. Sci.</title>
</titleInfo>
<part>
<date>1948</date>
<detail type="volume">
<caption>vol.</caption>
<number>51</number>
</detail>
<extent unit="pages">
<start>660</start>
<end>672</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit44">
<titleInfo>
<title>Protamin is an inhibitor of angiogenesis</title>
</titleInfo>
<name type="personal">
<namePart type="given">S.</namePart>
<namePart type="family">Taylor</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Folkman</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Taylor, S., and Folkman, J., (1982) Protamin is an inhibitor of angiogenesis. Nature, 297:307–312.</note>
<part>
<date>1982</date>
<detail type="volume">
<caption>vol.</caption>
<number>297</number>
</detail>
<extent unit="pages">
<start>307</start>
<end>312</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Nature</title>
</titleInfo>
<part>
<date>1982</date>
<detail type="volume">
<caption>vol.</caption>
<number>297</number>
</detail>
<extent unit="pages">
<start>307</start>
<end>312</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit45">
<titleInfo>
<title>Vascular endothelial cell growth factor: a new member of the platelet‐derived growth factor family</title>
</titleInfo>
<name type="personal">
<namePart type="given">E.</namePart>
<namePart type="family">Tischer</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Gospodarowicz</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">R.</namePart>
<namePart type="family">Mitchell</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M.</namePart>
<namePart type="family">Silva</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Schilling</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">K.</namePart>
<namePart type="family">Lau</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">T.</namePart>
<namePart type="family">Grisp</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J. C.</namePart>
<namePart type="family">Fiddes</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J. A.</namePart>
<namePart type="family">Abraham</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Tischer, E., Gospodarowicz, D., Mitchell, R., Silva, M., Schilling, J., Lau, K., Grisp, T., Fiddes, J. C., and Abraham, J. A., (1989) Vascular endothelial cell growth factor: a new member of the platelet‐derived growth factor family. Biochem. Biophys. Res. Commun., 165:1198–1206.</note>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>165</number>
</detail>
<extent unit="pages">
<start>1198</start>
<end>1206</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Biochem. Biophys. Res. Commun.</title>
</titleInfo>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>165</number>
</detail>
<extent unit="pages">
<start>1198</start>
<end>1206</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit46">
<titleInfo>
<title>Characterization of the receptor of Vascular Endothelial Growth Factor</title>
</titleInfo>
<name type="personal">
<namePart type="given">N.</namePart>
<namePart type="family">Vaisman</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D.</namePart>
<namePart type="family">Gospodarowicz</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">G.</namePart>
<namePart type="family">Neufeld</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Vaisman, N., Gospodarowicz, D., and Neufeld, G., (1990) Characterization of the receptor of Vascular Endothelial Growth Factor. J. Biol. Chem., 265:19461–19466.</note>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>265</number>
</detail>
<extent unit="pages">
<start>19461</start>
<end>19466</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Biol. Chem.</title>
</titleInfo>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>265</number>
</detail>
<extent unit="pages">
<start>19461</start>
<end>19466</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit47">
<titleInfo>
<title>Role of platelet‐derived growth factor and other growth factors in inflamation13</title>
</titleInfo>
<name type="personal">
<namePart type="given">N. F.</namePart>
<namePart type="family">Voelker</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host">
<titleInfo>
<title>Mediators of the inflamatory process</title>
</titleInfo>
<originInfo>
<publisher>Elsevier Science Publisher</publisher>
<place>
<placeTerm type="text">Amsterdam</placeTerm>
</place>
</originInfo>
<part>
<date>1989</date>
<extent unit="pages">
<start>45</start>
<end>56</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit48">
<titleInfo>
<title>Heparin and acidic fibroblast growth factor interact to decrease prostacyclin synthesis in human endothelial cells by affecting both, prostaglandin H synthetase and prostacyclin synthetase</title>
</titleInfo>
<name type="personal">
<namePart type="given">B. B.</namePart>
<namePart type="family">Wecksler</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Wecksler, B. B., (1990) Heparin and acidic fibroblast growth factor interact to decrease prostacyclin synthesis in human endothelial cells by affecting both, prostaglandin H synthetase and prostacyclin synthetase. J. Cell. Physiol., 142:514–522.</note>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>142</number>
</detail>
<extent unit="pages">
<start>514</start>
<end>522</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Cell. Physiol.</title>
</titleInfo>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>142</number>
</detail>
<extent unit="pages">
<start>514</start>
<end>522</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit49">
<titleInfo>
<title>Platelet derived growth factor receptors from a high affinity state in membrane preparations</title>
</titleInfo>
<name type="personal">
<namePart type="given">R. T.</namePart>
<namePart type="family">Williams</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">P. M.</namePart>
<namePart type="family">Trimble</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M. F.</namePart>
<namePart type="family">Lavin</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M. E.</namePart>
<namePart type="family">Sunday</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Williams, R. T., Trimble, P. M., Lavin, M. F., and Sunday, M. E., (1984) Platelet derived growth factor receptors from a high affinity state in membrane preparations. J. Biol. Chem., 259:5287–5294.</note>
<part>
<date>1984</date>
<detail type="volume">
<caption>vol.</caption>
<number>259</number>
</detail>
<extent unit="pages">
<start>5287</start>
<end>5294</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Biol. Chem.</title>
</titleInfo>
<part>
<date>1984</date>
<detail type="volume">
<caption>vol.</caption>
<number>259</number>
</detail>
<extent unit="pages">
<start>5287</start>
<end>5294</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit50">
<titleInfo>
<title>Effects of irradiation on the release of growth factors from cultured bovine, porcine and human endothelial cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">L.</namePart>
<namePart type="family">Witte</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Z.</namePart>
<namePart type="family">Fuks</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A.</namePart>
<namePart type="family">Haimovitz‐Friedman</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">I.</namePart>
<namePart type="family">Vlodavsky</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D. S.</namePart>
<namePart type="family">Goodman</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A.</namePart>
<namePart type="family">Eldor</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Witte, L., Fuks, Z., Haimovitz‐Friedman, A., Vlodavsky, I., Goodman, D. S., and Eldor, A., (1989) Effects of irradiation on the release of growth factors from cultured bovine, porcine and human endothelial cells. Cancer Res., 49:1253–1260.</note>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>49</number>
</detail>
<extent unit="pages">
<start>1253</start>
<end>1260</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Cancer Res.</title>
</titleInfo>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>49</number>
</detail>
<extent unit="pages">
<start>1253</start>
<end>1260</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit51">
<titleInfo>
<title>Enhancement of thrombin and ionomycin stimulated prostacyclin and platelet acting factor production in cultured endothelial cells by tumor promoting phorbol ester</title>
</titleInfo>
<name type="personal">
<namePart type="given">G. B.</namePart>
<namePart type="family">Zavoico</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J. K.</namePart>
<namePart type="family">Hrbolich</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M. A.</namePart>
<namePart type="family">Gimbrone</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A.</namePart>
<namePart type="family">Schafer</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Zavoico, G. B., Hrbolich, J. K., Gimbrone, M. A., and Schafer, A., (1990) Enhancement of thrombin and ionomycin stimulated prostacyclin and platelet acting factor production in cultured endothelial cells by tumor promoting phorbol ester. J. Cell. Physiol., 143:596–609.</note>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>143</number>
</detail>
<extent unit="pages">
<start>596</start>
<end>609</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Cell. Physiol.</title>
</titleInfo>
<part>
<date>1990</date>
<detail type="volume">
<caption>vol.</caption>
<number>143</number>
</detail>
<extent unit="pages">
<start>596</start>
<end>609</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit52">
<titleInfo>
<title>Role of prostaglandin E1 and copper in angiogenesis</title>
</titleInfo>
<name type="personal">
<namePart type="given">M.</namePart>
<namePart type="family">Ziche</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Jones</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">P. M.</namePart>
<namePart type="family">Gullino</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Ziche, M., Jones, J., and Gullino, P. M., (1982) Role of prostaglandin E1 and copper in angiogenesis. J. Natl. Cancer Inst., 69:475–482.</note>
<part>
<date>1982</date>
<detail type="volume">
<caption>vol.</caption>
<number>69</number>
</detail>
<extent unit="pages">
<start>475</start>
<end>482</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>J. Natl. Cancer Inst.</title>
</titleInfo>
<part>
<date>1982</date>
<detail type="volume">
<caption>vol.</caption>
<number>69</number>
</detail>
<extent unit="pages">
<start>475</start>
<end>482</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<identifier type="istex">D65D97CC8479F9BF9489CDDB588AF8E067E434AA</identifier>
<identifier type="ark">ark:/67375/WNG-CDHTF6T2-B</identifier>
<identifier type="DOI">10.1002/jcp.1041490108</identifier>
<identifier type="ArticleID">JCP1041490108</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 1991 Wiley‐Liss, Inc.</accessCondition>
<recordInfo>
<recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource>
<recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin>
<recordCreationDate encoding="w3cdtf">2019-11-15</recordCreationDate>
</recordInfo>
</mods>
<json:item>
<extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-CDHTF6T2-B/record.json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000994 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000994 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:D65D97CC8479F9BF9489CDDB588AF8E067E434AA
   |texte=   Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021